

Cover Story
By Matthew Bin Han Ong
Nearly 100 cancer patients and others gather for a march to University of Utah President David Pershing's office on April 24, calling for the reinstatement of Mary Beckerle as director and CEO of the Huntsman Cancer Institute.Cover Photo by Scott G Winterton, Deseret NewsA week after her abrupt firing, Mary Beckerle is back in her job as director and CEO of the Huntsman Cancer Institute.
In Brief


Drugs & Targets


Trending Stories
- She flew Black Hawks and battled cancer—now Col. Susan Fondy grapples with cuts to lymphedema research
- Rick and Mary Pazdur on facing “the other side of the stethoscope”
A few months before Mary died of ovarian cancer, the couple shared how this experience shaped their perspectives on oncology - First-ever financial toxicity tumor board aims to change the standard of care
Researchers focus on debt as a side effect of cancer, treatment amid cuts to Medicaid, NCI - HHS seems poised to exert control over USPSTF
Ransohoff: The task force is the pinnacle of evidence-based medicine - An overlooked immune cell population may offer new direction for cell and gene therapy
- In The Headlines: What happens when you apply a tumor board model to financial toxicity?